189 related articles for article (PubMed ID: 20427478)
1. Role of the TSC1-TSC2 complex in the integration of insulin and glucose signaling involved in pancreatic beta-cell proliferation.
Bartolomé A; Guillén C; Benito M
Endocrinology; 2010 Jul; 151(7):3084-94. PubMed ID: 20427478
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
3. Differential mitogenic signaling in insulin receptor-deficient fetal pancreatic beta-cells.
Guillen C; Navarro P; Robledo M; Valverde AM; Benito M
Endocrinology; 2006 Apr; 147(4):1959-68. PubMed ID: 16396989
[TBL] [Abstract][Full Text] [Related]
4. Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A.
Sacco A; Morcavallo A; Pandini G; Vigneri R; Belfiore A
Endocrinology; 2009 Aug; 150(8):3594-602. PubMed ID: 19443570
[TBL] [Abstract][Full Text] [Related]
5. High glucose induces suppression of insulin signalling and apoptosis via upregulation of endogenous IL-1beta and suppressor of cytokine signalling-1 in mouse pancreatic beta cells.
Venieratos PD; Drossopoulou GI; Kapodistria KD; Tsilibary EC; Kitsiou PV
Cell Signal; 2010 May; 22(5):791-800. PubMed ID: 20067833
[TBL] [Abstract][Full Text] [Related]
6. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
7. Insulin like growth factor-1-induced phosphorylation and altered distribution of tuberous sclerosis complex (TSC)1/TSC2 in C2C12 myotubes.
Miyazaki M; McCarthy JJ; Esser KA
FEBS J; 2010 May; 277(9):2180-91. PubMed ID: 20412061
[TBL] [Abstract][Full Text] [Related]
8. Insulin receptor isoform A confers a higher proliferative capability to pancreatic beta cells enabling glucose availability and IGF-I signaling.
Escribano O; Gómez-Hernández A; Díaz-Castroverde S; Nevado C; García G; Otero YF; Perdomo L; Beneit N; Benito M
Mol Cell Endocrinol; 2015 Jul; 409():82-91. PubMed ID: 25797178
[TBL] [Abstract][Full Text] [Related]
9. AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation.
Ning J; Clemmons DR
Mol Endocrinol; 2010 Jun; 24(6):1218-29. PubMed ID: 20363874
[TBL] [Abstract][Full Text] [Related]
10. Follicle-stimulating hormone increases tuberin phosphorylation and mammalian target of rapamycin signaling through an extracellular signal-regulated kinase-dependent pathway in rat granulosa cells.
Kayampilly PP; Menon KM
Endocrinology; 2007 Aug; 148(8):3950-7. PubMed ID: 17510244
[TBL] [Abstract][Full Text] [Related]
11. Palmitate affects insulin receptor phosphorylation and intracellular insulin signal in a pancreatic alpha-cell line.
Piro S; Maniscalchi ET; Monello A; Pandini G; Mascali LG; Rabuazzo AM; Purrello F
Endocrinology; 2010 Sep; 151(9):4197-206. PubMed ID: 20573722
[TBL] [Abstract][Full Text] [Related]
12. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway.
Zhang HH; Huang J; Düvel K; Boback B; Wu S; Squillace RM; Wu CL; Manning BD
PLoS One; 2009 Jul; 4(7):e6189. PubMed ID: 19593385
[TBL] [Abstract][Full Text] [Related]
13. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent.
Jaeschke A; Hartkamp J; Saitoh M; Roworth W; Nobukuni T; Hodges A; Sampson J; Thomas G; Lamb R
J Cell Biol; 2002 Oct; 159(2):217-24. PubMed ID: 12403809
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
[TBL] [Abstract][Full Text] [Related]
15. PI3K-C2α Knockdown Results in Rerouting of Insulin Signaling and Pancreatic Beta Cell Proliferation.
Leibiger B; Moede T; Paschen M; Yunn NO; Lim JH; Ryu SH; Pereira T; Berggren PO; Leibiger IB
Cell Rep; 2015 Oct; 13(1):15-22. PubMed ID: 26387957
[TBL] [Abstract][Full Text] [Related]
16. Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2).
Rolfe M; McLeod LE; Pratt PF; Proud CG
Biochem J; 2005 Jun; 388(Pt 3):973-84. PubMed ID: 15757502
[TBL] [Abstract][Full Text] [Related]
17. Both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signalling are required in epidermal growth factor-induced human trophoblast migration.
Qiu Q; Yang M; Tsang BK; Gruslin A
Mol Hum Reprod; 2004 Sep; 10(9):677-84. PubMed ID: 15235105
[TBL] [Abstract][Full Text] [Related]
18. Glucose regulates Foxo1 through insulin receptor signaling in the pancreatic islet beta-cell.
Martinez SC; Cras-Méneur C; Bernal-Mizrachi E; Permutt MA
Diabetes; 2006 Jun; 55(6):1581-91. PubMed ID: 16731820
[TBL] [Abstract][Full Text] [Related]
19. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR.
Zhang H; Cicchetti G; Onda H; Koon HB; Asrican K; Bajraszewski N; Vazquez F; Carpenter CL; Kwiatkowski DJ
J Clin Invest; 2003 Oct; 112(8):1223-33. PubMed ID: 14561707
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.
Ma L; Chen Z; Erdjument-Bromage H; Tempst P; Pandolfi PP
Cell; 2005 Apr; 121(2):179-93. PubMed ID: 15851026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
